Protein markers predict body composition during growth hormone treatment in short prepubertal children.

What Was Tested

The paper reports a study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over), published as a randomized controlled trial.

The aim of this study was to identify protein markers involved in the diverse anabolic and lipolytic remodelling of body composition during GH treatment.

Who Took Part

According to the abstract, 128 children were involved.

PubMed indexes the participants as young children and children, both men and women.

The study population consisted of 128 prepubertal children receiving GH treatment.

How the Study Was Run

The researchers set it up as a randomized study.

The children were allocated by chance, so the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) group and the comparison group should start out alike.

Thirty-nine were short as a result of GH deficiency, and 89 had idiopathic short stature (ISS).

Body composition was analysed by dual-energy X-ray absorptiometry (DXA), reliably estimating muscle mass from appendicular (arms and legs) lean soft tissue mass (LST).

DXA was also used to estimate appendicular bone mineral content (BMC) and fat mass for the total body.

What Was Measured

PubMed files the paper under topics including Absorptiometry, Photon, Body Composition, Bone Density, Dwarfism, Pituitary, Growth Hormone, Human Growth Hormone and Lipoproteins.

What This Means in Plain Language

The paper is a randomized study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 128 children.

The abstract goes on to report its results in about 4 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2013 (Clinical endocrinology), a journal based in England.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.